Bone Marrow Derived Stem Cells Mobilization for treatment of Asherman's syndrome, Atrophic endometrium, and Recurrent implantation failure
- Study HIC#:2000026217
- Last Updated:04/17/2024
Women with Asherman’s syndrome (AS), atrophic/thin endometrium (AE) or recurrent implantation failure (RIF). This trial is researching if women given the bone marrow stem cell stimulating drug can replenish stem cells in the endometrium to repair and thicken their endometrium and achieve a viable pregnancy. Participant’s own bone marrow stem cells are an effective medical therapy for the treatment of AS, AE or RIF syndrome.
- Age18 years - 40 years
- GenderFemale only
Contact Us
For more information about this study, including how to volunteer, contact:
Michele Frank, RN
- Phone Number: 1-203-785-6949
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
Women with Asherman’s syndrome (AS), atrophic/thin endometrium (AE) or recurrent implantation failure (RIF). This trial is researching if women given the bone marrow stem cell stimulating drug can replenish stem cells in the endometrium to repair and thicken their endometrium and achieve a viable pregnancy. Participant’s own bone marrow stem cells are an effective medical therapy for the treatment of AS, AE or RIF syndrome.
Eligibility Criteria
Women with Asherman’s syndrome (AS), atrophic/thin endometrium (AE) or recurrent implantation failure (RIF).
Principal Investigator
- Score: 1
